These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 6399108)
1. [Place and role of tissue plasminogen activator in the fibrinolysis process]. Wilczyńska M; Cierniewski C Postepy Hig Med Dosw; 1984; 38(4):481-97. PubMed ID: 6399108 [No Abstract] [Full Text] [Related]
3. [Tissue plasminogen activator: mechanism of action and thrombolytic properties]. Páramo JA; Collen D Sangre (Barc); 1984; 29(4-C):767-73. PubMed ID: 6393389 [No Abstract] [Full Text] [Related]
4. [The vascular wall and fibrinolysis--pharmacologic aspects]. Markwardt F Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):164-75. PubMed ID: 2427397 [TBL] [Abstract][Full Text] [Related]
5. Physiological consequences of loss of plasminogen activator gene function in mice. Carmeliet P; Schoonjans L; Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC Nature; 1994 Mar; 368(6470):419-24. PubMed ID: 8133887 [TBL] [Abstract][Full Text] [Related]
6. [The fibrinolytic system and its activators]. Seifried E Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223 [TBL] [Abstract][Full Text] [Related]
7. [Molecular mechanisms of blood coagulation and fibrinolysis activation]. Worowski K Postepy Hig Med Dosw; 1980; 34(3):189-233. PubMed ID: 6455654 [No Abstract] [Full Text] [Related]
8. Fibrinolysis mediated by tissue plasminogen activator. Disclosure of a kinetic transition. Norrman B; Wallén P; Rånby M Eur J Biochem; 1985 May; 149(1):193-200. PubMed ID: 3158522 [TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of plasminogen activators (review of the literature)]. Andreenko GV Lab Delo; 1984; (1):6-11. PubMed ID: 6199577 [No Abstract] [Full Text] [Related]
11. [Molecular interactions during fibrinolysis. Search for new plasminogen activators]. Maksimenko AV Mol Biol (Mosk); 1995; 29(1):38-60. PubMed ID: 7723763 [TBL] [Abstract][Full Text] [Related]
12. Histochemistry and assay of plasminogen activator. Pandolfi M Rev Eur Etud Clin Biol; 1972 Mar; 17(3):254-60. PubMed ID: 4262311 [No Abstract] [Full Text] [Related]
13. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia. Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740 [TBL] [Abstract][Full Text] [Related]
14. Peritoneal fibrinolysis: evidence for the efficiency of the tissue-type plasminogen activator. Moore KL; Bang NU; Broadie TA; Mattler LE; Marks CA J Lab Clin Med; 1983 Jun; 101(6):921-9. PubMed ID: 6682880 [TBL] [Abstract][Full Text] [Related]
15. The regulation by fibrinogen and fibrin of tissue plasminogen activator kinetics and inhibition by plasminogen activator inhibitor 1. Thelwell C; Longstaff C J Thromb Haemost; 2007 Apr; 5(4):804-11. PubMed ID: 17408411 [TBL] [Abstract][Full Text] [Related]